Peri-infarct quantification by cardiac magnetic resonance to predict outcomes in ischemic cardiomyopathy: prognostic systematic review and meta-analysis
H Haghbayan, N Lougheed, DP Deva… - Circulation …, 2019 - Am Heart Assoc
Background: In ischemic cardiomyopathy, cardiac magnetic resonance assessment of the
peri-infarct zone, a potential substrate for arrhythmogenesis, may serve as a novel …
peri-infarct zone, a potential substrate for arrhythmogenesis, may serve as a novel …
Dosimetric predictors of temporal lobe injury after intensity-modulated radiotherapy for T4 nasopharyngeal carcinoma: a competing risk study
J Huang, F Kong, RW Oei, R Zhai, C Hu, H Ying - Radiation Oncology, 2019 - Springer
Background In patients with T4 nasopharyngeal carcinoma (NPC), death may occur prior to
the occurrence of temporal lobe injury (TLI). Because such competing risk death precludes …
the occurrence of temporal lobe injury (TLI). Because such competing risk death precludes …
Rationale and design of the EU‐CERT‐ICD prospective study: comparative effectiveness of prophylactic ICD implantation
M Zabel, C Sticherling, R Willems, A Lubinski… - ESC heart …, 2019 - Wiley Online Library
Aims The clinical effectiveness of primary prevention implantable cardioverter defibrillator
(ICD) therapy is under debate. The EUropean Comparative Effectiveness Research to …
(ICD) therapy is under debate. The EUropean Comparative Effectiveness Research to …
Predicting defibrillator benefit in patients with cardiac resynchronization therapy: A competing risk study
Background Cardiac resynchronization therapy (CRT) reduces morbidity and mortality in
selected heart failure patients, but decision-making regarding selection of CRT-defibrillator …
selected heart failure patients, but decision-making regarding selection of CRT-defibrillator …
Risk of subsequent ventricular arrhythmia is higher in primary prevention patients with implantable cardioverter defibrillator than in secondary prevention patients
Y Zhou, S Zhao, K Chen, W Hua, Y Su, S Chen… - BMC Cardiovascular …, 2019 - Springer
Background Because of previous ventricular arrhythmia (VA) episodes, patients with
implantable cardioverter-defibrillator (ICD) for secondary prevention (SP) are generally …
implantable cardioverter-defibrillator (ICD) for secondary prevention (SP) are generally …
[HTML][HTML] 心源性猝死一级预防植入心律转复除颤器前非持续室性心动过速与植入后恰当治疗的关系
王震， 程中伟， 陈太波， 高鹏， 方全 - 协和医学杂志, 2019 - xhyxzz.pumch.cn
心源性猝死一级预防植入心律转复除颤器前非持续室性心动过速与植入后恰当治疗的关系 邮件
订阅 RSS 首页 关于本刊 1.期刊介绍 2.编委会 3.主编风采 投稿指南 1.投稿须知 2.版权转让协议 …
订阅 RSS 首页 关于本刊 1.期刊介绍 2.编委会 3.主编风采 投稿指南 1.投稿须知 2.版权转让协议 …
[PDF][PDF] Implantable cardioverter defibrillator for the prevention of sudden cardiac death: Systematic review and pooled analysis
A Albakri - Med Clin, 2019 - pdfs.semanticscholar.org
Implantable cardioverter defibrillator (ICD) is an innovative biomedical device designed to
detect and terminate malignant ventricular arrhythmias (VAs) with convincing evidence of …
detect and terminate malignant ventricular arrhythmias (VAs) with convincing evidence of …
Present criteria for prophylactic ICD implantation: insights from the EU-CERT-ICD (comparative effectiveness research to assess the use of primary ProphylacTic …
M Zabel, S Schlögl, A Lubinski, JH Svendsen… - Journal of …, 2019 - Elsevier
Background The clinical effectiveness of primary prevention implantable cardioverter
defibrillator (ICD) therapy is under debate. It is urgently needed to better identify patients …
defibrillator (ICD) therapy is under debate. It is urgently needed to better identify patients …